Current challenges and opportunities in treating glioblastoma
…, U Luesakul, N Muangsin, N Neamati - Pharmacological …, 2018 - ASPET
Glioblastoma multiforme (GBM), the most common and aggressive primary brain tumor, has
a high mortality rate despite extensive efforts to develop new treatments. GBM exhibits both …
a high mortality rate despite extensive efforts to develop new treatments. GBM exhibits both …
[HTML][HTML] Small molecule inhibitors of CXCR4
CXCR4 is a G-protein-coupled receptor involved in a number of physiological processes in
the hematopoietic and immune systems. The SDF-1/CXCR4 axis is significantly associated …
the hematopoietic and immune systems. The SDF-1/CXCR4 axis is significantly associated …
Discovery of novel small-molecule inhibitors of human epidermal growth factor receptor-2: Combined ligand and target-based approach
…, JARP Sarma, R Dayam, N Neamati - Journal of medicinal …, 2008 - ACS Publications
Consensus virtual screening models were generated and validated utilizing a set of known
human epidermal growth factor receptor-2 (HER2) inhibitors and modeled HER2 active and …
human epidermal growth factor receptor-2 (HER2) inhibitors and modeled HER2 active and …
Opportunities in discovery and delivery of anticancer drugs targeting mitochondria and cancer cell metabolism
D Pathania, M Millard, N Neamati - Advanced drug delivery reviews, 2009 - Elsevier
Cancer cells are characterized by self-sufficiency in the absence of growth signals, their
ability to evade apoptosis, resistance to anti-growth signals, sustained angiogenesis, …
ability to evade apoptosis, resistance to anti-growth signals, sustained angiogenesis, …
Protein disulfide isomerase: a promising target for cancer therapy
S Xu, S Sankar, N Neamati - Drug discovery today, 2014 - Elsevier
Highlights • PDI is an important oxidase, reductase, isomerase and molecular chaperone. •
PDI expression is up-regulated in select types of cancers. • Silencing PDI results in …
PDI expression is up-regulated in select types of cancers. • Silencing PDI results in …
[HTML][HTML] Integrin targeted therapeutics
M Millard, S Odde, N Neamati - Theranostics, 2011 - ncbi.nlm.nih.gov
Integrins are heterodimeric, transmembrane receptors that function as mechanosensors,
adhesion molecules and signal transduction platforms in a multitude of biological processes. As …
adhesion molecules and signal transduction platforms in a multitude of biological processes. As …
Discovery of an orally active small-molecule irreversible inhibitor of protein disulfide isomerase for ovarian cancer treatment
…, E Zandi, NA Petasis, N Neamati - Proceedings of the …, 2012 - National Acad Sciences
Protein disulfide isomerase (PDI), an endoplasmic reticulum chaperone protein, catalyzes
disulfide bond breakage, formation, and rearrangement. The effect of PDI inhibition on ovarian …
disulfide bond breakage, formation, and rearrangement. The effect of PDI inhibition on ovarian …
[HTML][HTML] Role of the CXCL8-CXCR1/2 axis in cancer and inflammatory diseases
H Ha, B Debnath, N Neamati - Theranostics, 2017 - ncbi.nlm.nih.gov
The chemokine receptors CXCR1/2 and their ligand CXCL8 are essential for the activation
and trafficking of inflammatory mediators as well as tumor progression and metastasis. The …
and trafficking of inflammatory mediators as well as tumor progression and metastasis. The …
Coumarin-based inhibitors of HIV integrase
H Zhao, N Neamati, H Hong, A Mazumder… - Journal of medicinal …, 1997 - ACS Publications
The structures of a large number of HIV-1 integrase inhibitors have in common two aryl units
separated by a central linker. Frequently at least one of these aryl moieties must contain 1,2-…
separated by a central linker. Frequently at least one of these aryl moieties must contain 1,2-…
Curcumin analogs with altered potencies against HIV-1 integrase as probes for biochemical mechanisms of drug action
A Mazumder, N Neamati, S Sunder… - Journal of medicinal …, 1997 - ACS Publications
We have previously reported the inhibitory activity of curcumin against human immunodeficiency
virus type one (HIV-1) integrase. In the present study, we have synthesized and tested …
virus type one (HIV-1) integrase. In the present study, we have synthesized and tested …